Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spain's austerity cull on hold - HTA and centralised procurement on track

This article was originally published in Clinica

Executive Summary

Two projects of significance to the medtech and pharma sectors in Spain took centre stage last week in government discussions centred around healthcare cost-cutting. The planned national health technology assessment (HTA) agency, to be modelled on the UK’s NICE, has been formally approved for passage into law; and there is progress with the planned expansion of the centralised vaccines-purchasing “platform” to include medtech and pharma – a proposed list of target products is close to being unveiled.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT099476

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel